Bellerophon Therapeutics Earning Date (BLPH)

USA |NASDAQ |USD

BLPH Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 - $-0.45 $-0.36
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 - - $0.00

Bellerophon Therapeutics's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

BLPH Earnings Date & History Chart

BLPH Earnings & Revenue Forecast

BLPH Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-2.36 $-2.52 $-2.20

BLPH Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-2.36 $-2.36 $-2.36

BLPH Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $3.58M $0.00 $7.16M

BLPH Earnings Date & Revenue History

BLPH Earnings History

|
Show More
Show More

BLPH Revenue History

|
Show More
Show More

Bellerophon Therapeutics Next Earnings Date & Report

BLPH Next Earnings Date & Report Preview: Jun 2022 (FQ)

BLPH's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

Bellerophon Therapeutics Previous Earnings Dates & Reports

BLPH Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Bellerophon Therapeutics's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

BLPH's earnings per share (EPS) was $-0.45, beating the consensus analysts forecast of $-0.54 by 16.80%.

The EPS was higher than the previous fiscal quarter (Dec 2021) by -0.16%, and higher than the same period a year before (Mar 2021) by -22.53%.

BLPH Previous Earnings Date & Report Recap: Dec 2021 (FY)

Bellerophon Therapeutics's previous annual earnings date was Mar 31, 2022 for its fiscal year ended Dec 31, 2021.

BLPH's earnings per share (EPS) was $-1.88, beating the consensus analysts forecast of $-2.22 by -15.32% , and higher than the previous year's EPS (Dec 2020) by -41.43%.

Revenues were $0.00.

The company reported a net income of $-17.76M.

Bellerophon Therapeutics reported a free cash flow of $-22.82M for its fiscal year, compared to $-19.88M a year ago.

The company ended the fiscal year with $955.00K in total debt, a decrease of -42.47% compared to the previous year.